BJCM
Blue Jay Capital Management Portfolio holdings
AUM
$147M
1-Year Return
64.18%
This Quarter Return
-8.1%
1 Year Return
+64.18%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$156M
AUM Growth
-$140M
(-47%)
Cap. Flow
-$132M
Cap. Flow
% of AUM
-84.59%
Top 10 Holdings %
Top 10 Hldgs %
75.5%
Holding
31
New
8
Increased
4
Reduced
4
Closed
15
Top Buys
| 1 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$14.1M |
| 2 |
Ionis Pharmaceuticals
IONS
|
+$12.9M |
| 3 |
Integra LifeSciences
IART
|
+$12.1M |
| 4 |
ABMD
Abiomed Inc
ABMD
|
+$11.7M |
| 5 |
PDCO
Patterson Companies, Inc.
PDCO
|
+$6.64M |
Top Sells
| 1 |
Intuitive Surgical
ISRG
|
+$20.2M |
| 2 |
Edwards Lifesciences
EW
|
+$19.9M |
| 3 |
Biogen
BIIB
|
+$17.8M |
| 4 |
ENDP
Endo International plc
ENDP
|
+$15.6M |
| 5 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$15M |
Sector Composition
| 1 | Healthcare | 84.17% |
| 2 | Consumer Staples | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Cooper Companies
COO
$13.3B
| $14.3M | 9.13% |
370,760
+10,760
| +3% | +$414K |
|
|
MJN
2
DELISTED
Mead Johnson Nutrition Company
MJN
| $14.1M | 9.04% |
+166,370
| New | +$14.1M |
|
3
Neurocrine Biosciences
NBIX
$14.1B
| $14.1M | 9.02% |
356,510
+156,450
| +78% | +$6.19M |
|
|
4
Ionis Pharmaceuticals
IONS
$10.1B
| $12.9M | 8.25% |
+318,490
| New | +$12.9M |
|
|
5
Integra LifeSciences
IART
$1.17B
| $12.1M | 7.75% |
+360,000
| New | +$12.1M |
|
|
ABMD
6
DELISTED
Abiomed Inc
ABMD
| $11.7M | 7.49% |
+123,590
| New | +$11.7M |
|
|
QGENF
7
DELISTED
QIAGEN NV
QGENF
| $10.6M | 6.79% |
475,000
+115,000
| +32% | +$2.57M |
|
|
STJ
8
DELISTED
St Jude Medical
STJ
| $10.5M | 6.69% |
190,140
+37,640
| +25% | +$2.07M |
|
9
Agilent Technologies
A
$34.9B
| $9.96M | 6.37% |
250,000
-35,000
| -12% | -$1.39M |
|
|
SHPG
10
DELISTED
Shire pic
SHPG
| $7.76M | 4.96% |
45,150
-46,880
| -51% | -$8.06M |
|
11
Quest Diagnostics
DGX
$20.5B
| $6.64M | 4.25% |
92,949
-82,211
| -47% | -$5.87M |
|
|
PDCO
12
DELISTED
Patterson Companies, Inc.
PDCO
| $6.64M | 4.24% |
+142,600
| New | +$6.64M |
|
13
Masimo
MASI
$8.01B
| $6.43M | 4.11% |
153,556
-61,444
| -29% | -$2.57M |
|
|
ALXN
14
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $6.27M | 4.01% |
+45,000
| New | +$6.27M |
|
15
BioMarin Pharmaceuticals
BMRN
$10.4B
| $6.19M | 3.96% |
+75,000
| New | +$6.19M |
|
16
Incyte
INCY
$16.2B
| $6.16M | 3.94% |
+85,000
| New | +$6.16M |
|
17
Assertio
ASRT
$78.3M
| – | – |
-133,750
| Closed | -$9.7M |
|
|
18
Biogen
BIIB
$21.2B
| – | – |
-58,161
| Closed | -$17.8M |
|
|
NVRO
19
DELISTED
NEVRO CORP.
NVRO
| – | – |
-190,000
| Closed | -$12.8M |
|
|
ENDP
20
DELISTED
Endo International plc
ENDP
| – | – |
-255,080
| Closed | -$15.6M |
|
|
CERN
21
DELISTED
Cerner Corp
CERN
| – | – |
-216,339
| Closed | -$13M |
|
|
WMGI
22
DELISTED
Wright Medical Group Inc
WMGI
| – | – |
-450,000
| Closed | -$10.9M |
|
|
IPXL
23
DELISTED
Impax Laboratories, Inc.
IPXL
| – | – |
-295,000
| Closed | -$12.6M |
|
|
CPHD
24
DELISTED
Cepheid Inc
CPHD
| – | – |
-290,000
| Closed | -$10.6M |
|
|
BXLT
25
DELISTED
BAXALTA INC COM STK (DE)
BXLT
| – | – |
-385,000
| Closed | -$15M |
|